LYNDON RAMIREZ: Open Payments
NPI 1750804530 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,822 in 100 payments from 15 companies in 2025. Trend: 2023 $1,506 · 2024 $1,383 · 2025 $1,822
Food & beverage: $1,822
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $388 |
| AstraZeneca Pharmaceuticals LP | 13 | $362 |
| PFIZER INC. | 18 | $230 |
| ABBVIE INC. | 12 | $167 |
| Amgen Inc. | 6 | $163 |
| Lilly USA, LLC | 12 | $150 |
| Medtronic, Inc. | 1 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 6 | $51 |
| Abbott Laboratories | 2 | $47 |
Products named: FARXIGA, Ozempic, Wegovy, EVENITY, NURTEC ODT, UBRELVY, MOUNJARO, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
